Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

The Effect of Smoking and Pre-Transplant Pulmonary Comorbidity on the Incidence of Lung Graft Versus Host Disease and Post Transplant Outcomes

Mohammed Kawari, Mariana Pinto Pereira, Mats Remberger, Ambrose Lau, Arjun Law, Rajat Kumar, Igor Novitzky-Basso, Wilson Lam, Ivan Pasic, Armin Gerbitz, Auro Viswabandya, Dennis Dong Hwan Kim, Jonas Mattsson, Fotios Michelis

Blood (2024) 144 (Supplement 1): 2151.

https://doi.org/10.1182/blood-2024-204249

Published: 2024

Journal Articles

Don't Fly and Freeze: Impact of Ex-Vivo-Time, Cell Concentration and Cryopreservation on the Composition of Allogeneic Stem Cell Grafts

Blood (2024) 144 (Supplement 1): 7261.

https://doi.org/10.1182/blood-2024-210038

Published: 2024

Journal Articles

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Ahmed Alnughmush, Ruah Alyamany, Mats Remberger, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Fotios Michelis, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 7285.

https://doi.org/10.1182/blood-2024-202708

Published: 2024

Journal Articles

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Caden Chiarello, Mats Remberger, Carol Chen, Armin Gerbitz, Dennis Dong Hwan Kim, Rajat Kumar, Wilson Lam, Arjun Law, Jonas Mattsson, Fotios Michelis, Ivan Pasic, Auro Viswabandya, Igor Novitzky-Basso

Blood (2024) 144 (Supplement 1): 7384.

https://doi.org/10.1182/blood-2024-203265

Published: 2024

Journal Articles

Impact of Cyclosporine Exposure Levels on Outcomes in Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis

Ahmed Alnughmush, Mats Remberger, Vathany Kulasingam, Ivan Pasic, Igor Novitzky-Basso, Arjun Law, Wilson Lam, Dennis Dong Hwan Kim, Armin Gerbitz, Auro Viswabandya, Rajat Kumar, Jonas Mattsson, Fotios Michelis

Blood (2024) 144 (Supplement 1): 7358.

https://doi.org/10.1182/blood-2024-202535

Published: 2024

Journal Articles

Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Blood (2024) 144 (Supplement 1): 7308.

https://doi.org/10.1182/blood-2024-202554

Published: 2024

Journal Articles

Strength to Endure: Superiority of MAC over RIC in Patients <65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis

Ruah Alyamany, Ahmed Alnughmush, Mats Remberger, Fotios Michelis, Arjun D. Law, Wilson Lam, Dennis Dong Hwan Kim, Ivan Pasic, Igor Novitzky-Basso, Armin Gerbitz, Rajat Kumar, Jonas Mattsson, Auro Viswabandya

Blood (2024) 144 (Supplement 1): 4863.

https://doi.org/10.1182/blood-2024-202536

Published: 2024

Journal Articles

Prevention of CMV/EBV Reactivation By Double-Specific T Cells in Patients after Allogeneic Stem Cell Transplantation: Results from the Randomized Phase I/IIa Multivir-01 Study

Blood (2023) 142 (Supplement 1): 6849.

https://doi.org/10.1182/blood-2023-178273

Published: 2023

Journal Articles

Substantial Alteration of Allogeneic Stem Cell Grafts Imposed By COVID-19 Pandemic Related Recommendations

Blood (2022) 140 (Supplement 1): 7563–7564.

https://doi.org/10.1182/blood-2022-167702

Published: 2022

Journal Articles

Influence of Conditioning Regimen Intensity on Outcomes Post-Allogeneic Transplantation for AML in Complete Morphological Remission

Tommy Alfaro, Fotios V. Michelis, Jonas Mattsson, Ivan Pasic, Mats Remberger, Auro Viswabandya, Dennis D.H. Kim, Igor Novitzky-Basso, Rajat Kumar, Jeffrey H. Lipton, Wilson Lam, Arjun D. Law, Armin Gerbitz

Blood (2022) 140 (Supplement 1): 12840–12841.

https://doi.org/10.1182/blood-2022-162279

Published: 2022

Journal Articles

ATG and Post-Transplant Cyclophosphamide Predisposes to Inferior Outcome When Using Cryopreserved Stem Cell Grafts

Igor Novitzky-Basso, Mats Remberger, Carol Chen, Ivan Pasic, Wilson Lam, Arjun Law, Armin Gerbitz, Auro Viswabandya, Jeffrey H. Lipton, Dennis Dong Hwan Kim, Rajat Kumar, Jonas Mattsson, Fotios Michelis

Blood (2021) 138 (Supplement 1): 479.

https://doi.org/10.1182/blood-2021-151744

Published: 2021

Journal Articles

Patient Age and Donor HLA Matching Can Stratify Allogeneic Hematopoietic Cell Transplantation (HCT) Patients into Prognostic Groups: A Collaborative Study

Sunu Cyriac, MD MBBS, Auro Viswabandya, MD, Zeyad Al-Shaibani, MD, Jeffrey H. Lipton, MD PhD, Rajat Kumar, MD, Wilson Lam, MD, Dennis Dong Hwan Kim, MD, Arjun Law, MDDM, Tobias Gedde-Dahl, MD PhD, Yngvar Floisand, MD PhD, Mats Remberger, PhD, Jonas Mattsson, MD, Fotios V. Michelis, MD PhD

Blood (2019) 134 (Supplement_1): 3341.

https://doi.org/10.1182/blood-2019-125941

Published: 2019

Journal Articles

Risk Factors for Primary and Secondary Graft Failure in Allogenic Hematopoietic Cell Transplantation: A Single Center Study

Zeyad Al-Shaibani, MD, Eshrak AL-Shaibani, MD, Mats Remberger, PhD, Wilson Lam, MD, Arjun Law, MD, Fotios V. Michelis, MD PhD, Auro Viswabandya, MD, Dennis Dong Hwan Kim, MD, Jeffrey H. Lipton, MD PhD, Jonas Mattson, MD PhD, Rajat Kumar, MD

Blood (2019) 134 (Supplement_1): 2046.

https://doi.org/10.1182/blood-2019-124208

Published: 2019

Journal Articles

Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Intensity

Hideki Nakasone, Mats Remberger, PhD, Lu Tian, PhD, Petter Brodin, MD PhD, Bita Sahaf, Fang Wu, Robert Lowsky, MD, Jonas Mattsson, MD PhD, Robert S. Negrin, MD, David B. Miklos, Everett Meyer, MD PhD

Blood (2014) 124 (21): 2537.

https://doi.org/10.1182/blood.V124.21.2537.2537

Published: 2014

Journal Articles

Graft Failure In Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Richard Olsson, MD, PhD, Daniel Moreno Berggren, MD, Olle Ringden, MD, PhD, Jonas Mattsson, MD, PhD, Mats Remberger, PhD

Blood (2013) 122 (21): 4559.

https://doi.org/10.1182/blood.V122.21.4559.4559

Published: 2013

Journal Articles

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Gabriel Afram, MD, Jose Antonio Pérez Simón, MD, PhD, Mats Remberger, PhD, Teresa Caballero-Velázquez, MD, PhD, Rodrigo Martino, MD, PhD, Jose Luis Piñana, MD, Olle Ringden, MD, Albert Esquirol, MD, Dolores Caballero, MD, PhD, Irene Garcia, MD, Lucía López-Corral, MD, PhD, Jordi Sierra, Oriana López-Godino, Per T. Ljungman, MD, PhD, Jesus F San Miguel, MD, PhD, Hans Hagglund, MD PhD

Blood (2013) 122 (21): 4611.

https://doi.org/10.1182/blood.V122.21.4611.4611

Published: 2013

Journal Articles

Hypogammaglobulinemia In Children Undergoing SCT: An Immunoglobulin Isotype Class Switch Arrest?

Henric Lindqvist, MD, Mats Remberger, PhD, Berit Sundberg, Mehmet Uzunel, PhD, Jacek Winiarski, MD, PhD, Mikael Sundin, MD, PhD

Blood (2013) 122 (21): 5473.

https://doi.org/10.1182/blood.V122.21.5473.5473

Published: 2013

Journal Articles

The Role Of Vitamin D In Pediatric Hematopoietic Stem Cell Transplantation

Magnus EA Hansson, MD, BA, Anna-Carin Norlin, MD, Brigitta Omazic, MD, PhD, Ann-Charlotte Wikström, MD, PhD, Jacek Winiarski, MD, PhD, Mats Remberger, PhD, Mikael Sundin, MD, PhD

Blood (2013) 122 (21): 5483.

https://doi.org/10.1182/blood.V122.21.5483.5483

Published: 2013

Journal Articles

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

Tapani Ruutu, MD PhD, Eeva Juvonen, MD PhD, Mats Remberger, MD PhD, Kari Remes, MD PhD, Liisa Volin, Jonas Mattsson, MD PhD, Anne Nihtinen, MD, Hans Hagglund, MD PhD, Olle Ringden, MD PhD

Blood (2011) 118 (21): 488.

https://doi.org/10.1182/blood.V118.21.488.488

Published: 2011

Journal Articles

NK cells expressing inhibitory KIR for non–self-ligands remain tolerant in HLA-matched sibling stem cell transplantation

Andreas T. Björklund, Marie Schaffer, Cyril Fauriat, Olle Ringdén, Mats Remberger, Christina Hammarstedt, A. John Barrett, Per Ljungman, Hans-Gustaf Ljunggren, Karl-Johan Malmberg

Blood (2010) 115 (13): 2686–2694.

https://doi.org/10.1182/blood-2009-07-229740

Published: 2010

NARROW

The Effect of Smoking and Pre-Transplant Pulmonary Comorbidity on the Incidence of Lung Graft Versus Host Disease and Post Transplant Outcomes

Don't Fly and Freeze: Impact of Ex-Vivo-Time, Cell Concentration and Cryopreservation on the Composition of Allogeneic Stem Cell Grafts

Superior Survival of Myeloablative over Reduced-Intensity Conditioning in MDS Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Both Pre- and Post-Allogeneic Stem Cell Transplant Ferritin Are Associated with Relapse: A Large Single Centre Retrospective Study

Impact of Cyclosporine Exposure Levels on Outcomes in Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis

Improved Outcomes with Myeloablative Conditioning in AML Patients below 65 Years Using a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide As Gvhd Prophylaxis

Strength to Endure: Superiority of MAC over RIC in Patients <65 Years Undergoing Stem Cell Transplantation Using ATG-Ptcy-CSA for Gvhd Prophylaxis

Prevention of CMV/EBV Reactivation By Double-Specific T Cells in Patients after Allogeneic Stem Cell Transplantation: Results from the Randomized Phase I/IIa Multivir-01 Study

Substantial Alteration of Allogeneic Stem Cell Grafts Imposed By COVID-19 Pandemic Related Recommendations

Influence of Conditioning Regimen Intensity on Outcomes Post-Allogeneic Transplantation for AML in Complete Morphological Remission

ATG and Post-Transplant Cyclophosphamide Predisposes to Inferior Outcome When Using Cryopreserved Stem Cell Grafts

Patient Age and Donor HLA Matching Can Stratify Allogeneic Hematopoietic Cell Transplantation (HCT) Patients into Prognostic Groups: A Collaborative Study

Risk Factors for Primary and Secondary Graft Failure in Allogenic Hematopoietic Cell Transplantation: A Single Center Study

Risks and Benefits of Sex-Mismatched Hematopoietic Cell Transplantation Differ By Conditioning Intensity

Graft Failure In Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation

Identification Of Patients At High Risk Of Chronic Graft-Versus-Host Disease: Gvhd Prophylaxis

Hypogammaglobulinemia In Children Undergoing SCT: An Immunoglobulin Isotype Class Switch Arrest?

The Role Of Vitamin D In Pediatric Hematopoietic Stem Cell Transplantation

Improved Survival with Ursodeoxycholic Acid Prophylaxis in Allogeneic Stem Cell Transplantation: Long-Term Follow-up of a Randomized Study of the Nordic Bone Marrow Transplantation Group

NK cells expressing inhibitory KIR for non–self-ligands remain tolerant in HLA-matched sibling stem cell transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only